NSE filing, NSE: MUTHOOTCAP. Summary written from the filing by ALFA Finder's alert engine.
Muthoot Capital Services Ltd: key numbers
- Share price
- ₹188.41
- Market cap
- ₹315.0 Cr
- Revenue (annual)
- ₹620.5 Cr
- Net profit (annual)
- ₹11.17 Cr
- P/E (TTM)
- 13.1×Sector 19.8×
- Promoter holding
- 63.33%+0.00% QoQ
- FII holding
- 1.24%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Muthoot Capital Services Ltd
All →Muthoot Capital Services Debt & Borrowing: ₹0.22 Cr
Muthoot Capital Services confirmed monthly interest payment of ₹0.22 Crore on NCDs under Reg 57(1). The underlying NCD issue size is ₹25 Crore.
- Value
- ₹0.22 Cr
Muthoot Capital Services Debt & Borrowing: ₹25 Cr
Muthoot Capital Services fully redeemed its Series 05/2024-25 NCDs on 29 October 2026, paying Rs 25.00 Crore on final redemption. Interest was paid on the same date.
- Value
- ₹25.00 Cr
Muthoot Capital Services Debt & Borrowing: ₹1.23 Cr
Muthoot Capital paid Rs 1.23 Crore monthly interest across two listed NCD series on October 28, 2026. Both series carry a 10% coupon with payment on schedule.
- Value
- ₹1.23 Cr
Muthoot Capital Services Debt & Borrowing: ₹0.76 Cr
Muthoot Capital paid ₹0.76 Crore NCD interest on October 23, 2026, one day before the due date. No delay or frequency change was reported.
- Value
- ₹0.76 Cr
Muthoot Capital Services Debt & Borrowing: ₹0.98 Cr
Muthoot Capital Services paid Rs.0.98 Crore of monthly interest on its MCSL 04/2025-26 NCDs on 22 October 2026. The payment relates to a Rs.125 Crore secured debenture series.
- Value
- ₹0.98 Cr
Muthoot Capital Services Debt & Borrowing: ₹1.03 Cr
Muthoot Capital Services paid ₹1.03 Crore monthly interest on NCDs (ISIN: INE296G07218). This is a routine Reg 57(1) debt-servicing certification.
- Value
- ₹1.03 Cr
Other board meeting date announcements
All →Novartis India Board Meeting Date
Evonile Pharma will hold a board meeting on November 4, 2026 to approve the rights issue letter of offer. BSE granted in-principle approval for the rights issue.
CHD Chemicals Board Meeting Date
CHD Chemicals intimated a board meeting on 04 Nov 2026 to consider unaudited half-yearly results for September 2026. Trading window remains closed until 06 Nov 2026.
Max Estates Board Meeting Date
Max Estates Limited has informed exchanges that its board will meet on 4 November 2026 to consider unaudited results for the quarter and half year ended 30 September 2026. The trading window stays closed until 6 November 2026.
GKP Printing & Packaging Board Meeting Date
G.K.P. Printing & Packaging announced a board meeting on 4 November 2026 to approve unaudited results for the quarter ended 30 September 2026. Trading window has been closed for insiders since 1 October 2026.
ADF Foods Board Meeting Date
ADF Foods will hold a board meeting on November 5, 2026 to consider unaudited results for the quarter and half year ended September 30, 2026. The meeting will also consider an interim dividend for FY2026-27.
MKP Mobility Board Meeting Date
MKP Mobility will hold a board meeting on November 6, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window remains closed until 48 hours after results.